Kirenaga Partners is pleased to announce it completed a Series A investment in Violet Defense Group, a technology leader in providing ultraviolet lighting solutions for germ disinfection, as well as agricultural lighting solutions for indoor growing.
Orlando-based Violet Defense utilizes its patented ultraviolet lighting technology to provide full-spectrum germ-killing. Violet Defense’s Surface and Air Germ Elimination (S.A.G.E.) devices can be used in mobile deployments or permanently installed, and their products are currently used in operating rooms, hotels, schools, ambulances, food processing, and athletic facilities. Violet Defense has previously announced collaborations with Siemens and the Orlando Magic, and most recently, is working with Koch Industries in a design collaboration to address PPE and mask issues associated with the COVID-19 crisis.
The investment, led by Kirenaga with participation from existing investor Northwestern University, comes at a time when demand for virus-killing solutions is increasing due to COVID-19. Violet Defense has raised more than $10 million in venture funding, with the vast majority provided by Kirenaga.
Violet Defense expects to use the proceeds to expand its management team, invest in next generation products for both the domestic and international marketplace, and rapidly ramp up manufacturing capacity to meet increased customer demand.
For more information, please contact:
Kirenaga Partners
Dave Scalzo
Managing Partner
(914) 202-6046
david.scalzo@kirenaga.com
Leighton Yenor
Marketing
(407) 575-3918
leighton.yenor@kirenaga.com
Violet Defense
Terrance Berland
Chief Executive Officer
(407) 433-1104 ext 1004
tberland@violetdefense.com
Jessica Jones
Marketing
(407) 433-1104 ext 1002
jjones@violetdefense.com